Chicago CMO opens potent small molecule site

By Fiona BARRY

- Last updated on GMT

Regis Technologies will offer an HPAPI service
Regis Technologies will offer an HPAPI service

Related tags Pharmacology Manufacturing

Contract manufacturing organisation Regis Technologies has added an HPAPI (highly potent active pharmaceutical ingredient) service.

The Chicago-based company will manufacture materials for small molecule oncology drugs, and linkers and payloads for antibody drug conjugates. A Potent Compound Suite will allow cGMP manufacturing up to 1kg per batch.

HPAPI production requires specialised facilities to minimise contamination risks. The site is equipped withisolators, laminar flow hoods and local exhaust ventilation.

The facility has a containment performance target (CPT) set to 50 ng/m3, based on the occupational exposure limits (OELs) of the specific APIs to be manufactured there.

Regis already operates a 36,000 sq ft cGMP facility in Morton Grove, Illinois. As well as cGMP API manufacturing, it performs chiral separations, scale-up, and commercial manufacturing. ​ 

Related news

Show more

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Related suppliers

Follow us

Products

View more

Webinars